However, it remains to be determined if intestinal barrier dysfunction associated with later stages of the disease e.g., MASH and fibrosis is also unrelated to TNFα and if this is also true for humans with MASLD. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.